Application

18015445 · POLYMORPHS OF A GABAA ALPHA5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

Filed 2023-01-10 · Granted The official file ↗ · Art unit 1624 · Examiner Daniel John Burkett Hard · CPC A61P 25/16 · AGENEBIO, INC. · Leason Ellis LLP (Life Sciences)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

33.1 mo

to disposition 40.8 mo

Statutes raised

103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.